Evaluation of Actinic Keratosis as a Risk Factor for Subsequent Nonskin Cancer Risk
Open Access
- 22 April 2025
- journal article
- Published by Elsevier in JID Innovations
- Vol. 5 (4) , 100374
Abstract
No abstract availableKeywords
Funding Information
- Wayne and Gladys Valley Foundation
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (K24AR069760)
- Robert Wood Johnson Foundation
- Ellison Medical Foundation
- National Cancer Institute (R01CA231264, R01CA241623)
This publication has 17 references indexed in Scilit:
- Skin Cancers in Medicare Beneficiaries With Actinic KeratosesJAMA Dermatology, 2023
- Ten-Year Follow-up of Persons With Sun-Damaged Skin Associated With Subsequent Development of Cutaneous Squamous Cell CarcinomaJAMA Dermatology, 2021
- Use and Cost of Actinic Keratosis Destruction in the Medicare Part B Fee-for-Service Population, 2007 to 2015JAMA Dermatology, 2018
- Variation in the Cost of Managing Actinic KeratosisJAMA Dermatology, 2017
- Primary Care Review of Actinic Keratosis and Its Therapeutic Options: A Global PerspectiveDermatology and Therapy, 2015
- Th9 Cells: A Novel CD4 T-cell Subset in the Immune War against CancerCancer Research, 2015
- Risk factors for actinic keratosis in eight European centres: a case-control studyBritish Journal of Dermatology, 2012
- Dermatopathology of skin cancer in solid organ transplant recipientsTransplantation Reviews, 2010
- Predisposing factors of actinic keratosis in a North-West German populationEuropean Journal Of Dermatology, 2009
- Role of TGF-? in immune-evasion of cancerMicroscopy Research and Technique, 2001